Neurobiology of Huntington's Disease Applications to Drug Discovery

Highlighting advances in the discovery and development of new drug therapies for neurodegenerative disorders, Neurobiology of Huntington's Disease focuses on the many aspects of the research on drugs to treat Huntington's disease. It discusses genetics, genomics, and proteomics, and the la...

Full description

Saved in:
Bibliographic Details
Main Authors Lo, Donald C, Hughes, Robert E
Format eBook
LanguageEnglish
Published Milton CRC Press 2011
Taylor & Francis Group
Edition1
SeriesFrontiers in neuroscience
Subjects
Online AccessGet full text
ISBN0849390001
9780849390005
DOI10.1201/EBK0849390005

Cover

Abstract Highlighting advances in the discovery and development of new drug therapies for neurodegenerative disorders, Neurobiology of Huntington's Disease focuses on the many aspects of the research on drugs to treat Huntington's disease. It discusses genetics, genomics, and proteomics, and the latest in high-throughput and high-content screening. The authors provide introductory background as well as highly sophisticated information on current and future directions of research. Exploring the interplay between academic and industrial research, the investment community, and non-profit contributors, the book also examines the practical realities of preclinical testing, clinical testing strategies, and, ultimately, clinical usage.
AbstractList In 1993, the genetic mutation responsible for Huntington's disease (HD) was identified. Considered a milestone in human genomics, this discovery has led to nearly two decades of remarkable progress that has greatly increased our knowledge of HD, and documented an unexpectedly large and diverse range of biochemical and genetic perturbations that seem to result directly from the expression of the mutant huntingtin gene. Neurobiology of Huntington's Disease: Applications to Drug Discoverypresents a thorough review of the issues surrounding drug discovery and development for the treatment of this paradigmatic neurodegenerative disease. Drawing on the expertise of key researchers in the field, the book discusses the basic neurobiology of Huntington's disease and how its monogenic nature confers enormous practical advantages for translational research, including the creation of robust experimental tools, models, and assays to facilitate discovery and validation of molecular targets and drug candidates for HD. Written to support future basic research as well as drug development efforts, this volume: Covers the latest research approaches in genetics, genomics, and proteomics, including high-throughput and high-content screening Highlights advances in the discovery and development of new drug therapies for neurodegenerative disorders Examines the practical realities of preclinical testing, clinical testing strategies, and, ultimately, clinical usage While the development of effective drug treatments for Huntington's disease continues to be tremendously challenging, a highly interactive and cooperative community of researchers and clinical investigators now brings us to the threshold of potential breakthroughs in the quest for therapeutic agents. The impressive array of drug discovery resources outlined in the text holds much promise for treating this devastating disease, providing hope to long-suffering Huntington's disease patients and their families.
Highlighting advances in the discovery and development of new drug therapies for neurodegenerative disorders, Neurobiology of Huntington's Disease focuses on the many aspects of the research on drugs to treat Huntington's disease. It discusses genetics, genomics, and proteomics, and the latest in high-throughput and high-content screening. The authors provide introductory background as well as highly sophisticated information on current and future directions of research. Exploring the interplay between academic and industrial research, the investment community, and non-profit contributors, the book also examines the practical realities of preclinical testing, clinical testing strategies, and, ultimately, clinical usage.
Author Lo, Donald C
Hughes, Robert E
Author_xml – sequence: 1
  fullname: Lo, Donald C
– sequence: 2
  fullname: Hughes, Robert E
BookMark eNpVkL1PwzAQxY34EG3pyN4BqWIonB078Y20BIqoYEGIzXISp4QGG-y0pf89KYWBW06n97t7p9clB9ZZQ8gphQvKgF6m43uQHCMEALFHusAZUsaYeNlvhz-FHpGORKRCxMCOST-EN9guMIxAdMjZg1l6l1WudvPNwJWD6dI2lZ03zg7D4LoKRgdzQg5LXQfT_-098nyTPk2mo9nj7d3kajbSLEb6Ncq5SRLEWItCcokJjXMhZNlWVgJmArksIgm8TCjHREeUSRGJnAKPDS9QRz1yvjusw8Ksw6urm6BWtcmcWwSFiaSctc9LJmTLDnfsh3efSxMa9YPlxjZe1yodTyiHeOvQI-mOrGzp_LteO18XqtGb2vnSa5tXYWdAQW2TVf-SVSvjQ-Usi74BdC5riw
ContentType eBook
Copyright 2011 by Taylor & Francis Group, LLC
Copyright_xml – notice: 2011 by Taylor & Francis Group, LLC
DEWEY 616.85107
DOI 10.1201/EBK0849390005
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISBN 042912225X
9781420008258
9780429122255
1420008250
Edition 1
Editor Lo, Donald C.
Hughes, Robert E.
Editor_xml – sequence: 1
  givenname: Donald C.
  surname: Lo
  fullname: Lo, Donald C.
– sequence: 2
  givenname: Robert E.
  surname: Hughes
  fullname: Hughes, Robert E.
ExternalDocumentID 9781420008258
EBC1406285
10_1201_EBK0849390005_version2
GroupedDBID 20A
5~G
AABBV
ABEQL
ABHFA
ABXRF
ACBYE
ADQWE
ADYHE
AEUHU
AINFC
AIXXW
AKSCQ
ALMA_UNASSIGNED_HOLDINGS
ATPON
AXE
AXO
AZZ
BBABE
BPDOF
CZQ
CZZ
EBATF
ENV
INALI
JG1
JTX
MYL
NEQ
S.C
ABYEM
ABYSD
AXTGW
ID FETCH-LOGICAL-a2691x-c4e77996a5d8489716c558ffffbf09b5948d3804f71497a3128535c1046e4d9a3
ISBN 0849390001
9780849390005
IngestDate Fri Nov 08 02:47:37 EST 2024
Fri May 30 21:11:50 EDT 2025
Tue Aug 19 03:07:41 EDT 2025
IsPeerReviewed false
IsScholarly false
Keywords Htt Fragment
Hd Subject
Expand CAG Repeat
Mutant Huntingtin
Mutant Htt
Hd Model
Ef Cacy
CAG Expansion
Repeat Length
Transgenic Mouse
CAG Repeat Length
RVG Peptide
Hd Mouse
polyQ Disease
Manifest Hd
Hd Patient
Hd Therapy
CAG Repeat
Hd Pathogenesis
Wild Type Htt
Target Validation
Ef Cacy Studies
Antisense Oligonucleotide
Hd Mouse Model
LCCallNum_Ident RC394.H85
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-a2691x-c4e77996a5d8489716c558ffffbf09b5948d3804f71497a3128535c1046e4d9a3
OCLC 899155602
PQID EBC1406285
PageCount 342
ParticipantIDs askewsholts_vlebooks_9781420008258
proquest_ebookcentral_EBC1406285
informaworld_taylorfrancisbooks_10_1201_EBK0849390005_version2
PublicationCentury 2000
PublicationDate 2011
2010
2010-07-02
PublicationDateYYYYMMDD 2011-01-01
2010-01-01
2010-07-02
PublicationDate_xml – year: 2011
  text: 2011
PublicationDecade 2010
PublicationPlace Milton
PublicationPlace_xml – name: Milton
PublicationSeriesTitle Frontiers in neuroscience
PublicationYear 2011
2010
Publisher CRC Press
Taylor & Francis Group
Publisher_xml – name: CRC Press
– name: Taylor & Francis Group
SSID ssj0000529305
ssib056456610
Score 1.8463413
Snippet Highlighting advances in the discovery and development of new drug therapies for neurodegenerative disorders, Neurobiology of Huntington's Disease focuses on...
In 1993, the genetic mutation responsible for Huntington's disease (HD) was identified. Considered a milestone in human genomics, this discovery has led to...
SourceID askewsholts
proquest
informaworld
SourceType Aggregation Database
Publisher
SubjectTerms Huntington's disease
Neuropharmacology
Subtitle Applications to Drug Discovery
TableOfContents Front cover -- Contents -- Series Preface -- Preface -- Editors -- Contributors -- Chapter 1: Huntington's Disease -- Chapter 2: Huntington's Disease Pathogenesis -- Chapter 3: Protein Interactionsand Target Discovery inHuntington's Disease -- Chapter 4: Target Validation forHuntington's Disease -- Chapter 5: High-Throughput andHigh-Content Screeningfor Huntington'sDisease Therapeutics -- Chapter 6: Value of InvertebrateGenetics and Biology toDevelop Neuroprotectiveand Preventive Medicinein Huntington's Disease -- Chapter 7: Mouse Models forValidating PreclinicalCandidates forHuntington's Disease -- Chapter 8: PharmaceuticalDevelopment forHuntington's Disease -- Chapter 9: RNA- and DNABasedTherapies forHuntington's Disease -- Chapter 10: Recombinant Intrabodiesas Molecular Tools andPotential Therapeuticsfor Huntington's Disease -- Chapter 11: Biomarkers to Enablethe Developmentof NeuroprotectiveTherapies forHuntington's Disease -- Chapter 12: Huntington's Disease -- Index -- Color Inserts: -- Back cover
Title Neurobiology of Huntington's Disease
URI https://www.taylorfrancis.com/books/9780429122255
https://ebookcentral.proquest.com/lib/[SITE_ID]/detail.action?docID=1406285
https://www.vlebooks.com/vleweb/product/openreader?id=none&isbn=9781420008258&uid=none
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFA-ygbiTnzi_KDLwVO1H0qYXD5bJUOZBpgwvJV-9KBvYboh_vS9p165zCGoPoQ0hoe-F95W830OoF0qmUsGFTZgvbNDX2OauTs6B7eMwphQ2oYHhQzB4wndjMq5D6Sa7JOeX4nNtXslfuAp9wFedJfsLzlaTQge8A3-hBQ5Du2L8Vp8LsKVZjZ9kQvGm4IOx48JMQ2pWpy6yDlE2PPr4MW7cvyhcPRd7hT9H1wo-zwDu92_uHYoj31QCrSV8de9OW_wwMmmMS-ZFZA4UWdvDgadlQ_xSGZUabiZYGFkFYjqYCA4pAUthuqvGdB3UYdkrSGiQ3nm2ggD7TeMZNT7aRm2lczt20Iaa7KLNYXmvYA_1lglqTVOrJuhFZpXk3EfPt_1RPLDL-hE284LI_bAFVmEIDh0jkmKqwbIEITSFh6dOxDVSjfSpg9MQ_MSQ-aCriU-EPvZWWEbMP0CtyXSiDpEF3SRShAtXV0J3aCS5xCzVqefgZMqgi86X_jqZv5mz7ixpcK6LrpeJkeQmKJMWFVSK8T9zqIusBfkSs0B5gxeGx-Ap63TYo_-ucYy26k15glr5-0ydguGV8zOzL74AlNQoTw
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.title=Neurobiology+of+Huntington%27s+Disease&rft.date=2011-01-01&rft.pub=CRC+Press&rft.isbn=9781420008258&rft_id=info:doi/10.1201%2FEBK0849390005&rft.externalDocID=10_1201_EBK0849390005_version2
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fvle.dmmserver.com%2Fmedia%2F640%2F97814200%2F9781420008258.jpg